Literature DB >> 9149182

Gastrointestinal manifestations of progressive systemic sclerosis.

G Lock1, A Holstege, B Lang, J Schölmerich.   

Abstract

Management of patients with progressive systemic sclerosis requires a thorough gastroenterological examination and a profound knowledge of possible gastrointestinal manifestations of the disease. The esophagus is the gastrointestinal segment most often involved. Smooth muscle atrophy leads to a loss of esophageal peristalsis, a defect of the lower esophageal sphincter, and gastric hypomotility, thus predisposing to severe reflux esophagitis. A rational diagnostic approach includes standard manometry and endoscopy. The prevention of strictures is the main aim of therapeutic efforts that may consist of lifestyle changes, prokinetic drugs, long-term application of proton pump inhibitors, and, if inevitable, surgical intervention. Involvement of the small intestine and colon is less common but may lead to life-threatening complications like chronic pseudoobstruction or pneumatosis cystoides intestinalis. The main therapeutic options consist of antibiotics for bacterial overgrowth and nutritional supplementation. Recently, a preliminary study with octreotide yielded promising results. Anorectal dysfunction can lead to fecal incontinence or rectal prolapse.

Entities:  

Mesh:

Year:  1997        PMID: 9149182

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  34 in total

1.  A case of pseudoobstruction of the intestine associated with scleroderma dramatically responding to antibiotics.

Authors:  Hiroaki Itou; Masahiro Iizuka; Kenichi Shindo; Shiho Konno; Sumio Watanabe
Journal:  J Gastroenterol       Date:  2006-07       Impact factor: 7.527

2.  Gastrojejunostomy and duodenojejunostomy for megaduodenum in systemic sclerosis sine scleroderma: report of a case.

Authors:  Katsuyoshi Kudoh; Chikashi Shibata; Yuji Funayama; Kouhei Fukushima; Ken-Ichi Takahashi; Hitoshi Ogawa; Yasuhiro Sagami; Yasuhiko Hirabayashi; Takuya Moriya; Iwao Sasaki
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.199

Review 3.  The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases: report of three cases and review of the literature.

Authors:  Cumali Efe; Ersan Ozaslan; Narin Nasiroglu; Hasan Tunca; Tugrul Purnak; Emin Altiparmak
Journal:  Dig Dis Sci       Date:  2009-10-14       Impact factor: 3.199

4.  Acute acalculous cholecystitis in systemic sclerosis.

Authors:  Takao Nagashima; Toshimi Imai; Kazuko Matsumoto; Sachiko Onishi; Shino Takatori; Masahiro Iwamoto; Seiji Minota
Journal:  Rheumatol Int       Date:  2009-10-23       Impact factor: 2.631

5.  Videofluorography swallow study of patients with systemic sclerosis.

Authors:  S Russo; G Lo Re; M Galia; A Reginelli; V Lo Greco; T D'Agostino; G La Tona; F Coppolino; R Grassi; M Midiri; R Lagalla
Journal:  Radiol Med       Date:  2009-06-26       Impact factor: 3.469

6.  Management of gastrointestinal involvement in scleroderma.

Authors:  Vivek Nagaraja; Zsuzsanna H McMahan; Terri Getzug; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2015-03-01

7.  Successful treatment of prokinetic-resistant intestinal pseudo-obstruction and pneumatosis cystoides intestinalis in systemic sclerosis with metronidazole.

Authors:  Masaaki Fujita; Yumiko Nakano; Masato Yagita
Journal:  Rheumatol Int       Date:  2017-02-17       Impact factor: 2.631

8.  Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument.

Authors:  Dinesh Khanna; Daniel E Furst; Paul Maranian; James R Seibold; Ann Impens; Maureen D Mayes; Philip J Clements; Terri Getzug; Ron D Hays
Journal:  J Rheumatol       Date:  2011-07-01       Impact factor: 4.666

Review 9.  Classification of oesophageal motility abnormalities.

Authors:  S J Spechler; D O Castell
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

10.  The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters.

Authors:  J N Kimmel; D A Carlson; M Hinchcliff; M A Carns; K A Aren; J Lee; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2016-02-27       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.